Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Announces the University of Oxford Selected as the Winning Recipient in GeoMx Digital Spatial Profiler Grant Program
DSP to be Applied to Transplant Research of Regulatory T Cell Therapy in Kidney Transplantation SEATTLE , Oct. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced
View HTML
Toggle Summary NanoString to Present at the Morgan Stanley Global Healthcare Conference
SEATTLE , Sept. 10, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2018 Morgan Stanley Global Healthcare
View HTML
Toggle Summary NanoString Launches Priority Site Program for New GeoMx Digital Spatial Profiler
Oversubscribed Early Access Launch Closes with Five DSP Beta Instruments Designated for Leading Academic and Industrial Research Facilities Now Taking Orders for 2019 Delivery of Commercial GeoMx Digital Spatial Profiler SEATTLE , Sept. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString to Present at the Baird 2018 Global Healthcare Conference
SEATTLE , Aug. 22, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Baird 2018 Global Healthcare
View HTML
Toggle Summary NanoString Technologies Announces Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
SEATTLE , Aug. 13, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the underwriters of its previously announced underwritten public offering have exercised their
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for Second Quarter of 2018
SEATTLE , Aug. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2018. Second Quarter Financial Highlights Total product
View HTML
Toggle Summary NanoString Expands Centers of Excellence Program and Initiates Early Access Launch for Digital Spatial Profiling
Two Leading Centers to Explore Spatial Genomics Synergies with Single-Cell Biology, Next-Generation Sequencing, and Advanced Imaging Technologies Announces Early Access Launch for Five Additional Beta Instruments SEATTLE , Aug. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.
View HTML
Toggle Summary NanoString Technologies Announces Closing of Public Offering of 4,000,000 Shares of Common Stock
SEATTLE , July 23, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 4,000,000 shares of its
View HTML
Toggle Summary NanoString Technologies Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
SEATTLE , July 17, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at a price
View HTML
Toggle Summary NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE , July 16, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it intends to offer and sell, subject to market and other conditions, $50 million of its
View HTML